Hospital Britanico de Buenos Aires /ID# 168081

Ciudad Autonoma de Buenos Aire, Ciuadad Autonoma de Buenos Aires 1280

0 studies enrolling now · 1 studies all time

What they study most

Crohn's Disease

Studies at this site

• A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment — Completed